1.	O’Connell TX, Horita TJ, Kasravi B. Understanding and interpreting serum protein electrophoresis. Am Fam Physician. 2005;71(1):105-12. https://pubmed.ncbi.nlm.nih.gov/15663032 
2.	Murray RK, Jacob M, Varghese J. Plasma proteins and immunoglobulins. In: Murray RK, Bender DA, Botham Km, Kennelly PJ, Rodwell VW, Weil AP, eds. Harper's Illustrated Biochemistry. 29th ed. New York: McGraw-Hill Medical; 
3.	Tuazon SA. Serum Protein Electrophoresis. 2014[cited [cited 2015 Mar 30]]. 
4. Techniques for protein electorphoresis. In: Keren DF, ed. Protein Electrophoresis in Clinical Diagnosis. New York: Oxford University Press; 2003. :15-32. https://doi.org/10.1201/b13302-3 
5.	Rajkumar VS. Recognition of monoclonal proteins. UpToDate. 2013[cited [cited 2018 Mar 12]]. 
6. Protein identified by serum protein electrophoresis. Keren DF, ed. Protein Electrophoresis in Clinical Diagnosis. New York: Oxford University Press; 2003. :63-108. 
7.     UKC Maribor. Seznam preiskav z referenčnimi vrednostmi in enotami. Referenčne vrednosti za elektroforezo serumskih proteinov. 2014. 
8. Kyle RA, Katzmann JA, Lust JA, Dispenzieri A. Clinical indications and applications of electrophoresis and immunofixation. In: Rose NR, Hamilton RG, Betrick B, eds. Manual of Clinical Laboratory Immunology. 6th ed. Washington (DC): ASM Press; 2002. :66-70. 
9.     Davenport RD, Keren DF. Oligoclonal bands in cerebrospinal fluids: significance of corresponding bands in serum for diagnosis of multiple sclerosis. Clinical Chemistry. 1988;34(4):764-5. https://pubmed.ncbi.nlm.nih.gov/3359616 
10. Conditions associated with monoclonal gammopathies. Keren DF, ed. Protein Electrophoresis in Clinical Diagnosis. New York: Oxford University Press; 2003. :145-216. https://doi.org/10.1201/b13302-7 
11.	Therneau TM, Kyle RA, Melton LJ, Larson DR, Benson JT, Colby CL, et al. Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition. Mayo Clin Proc. 2012;87(11):1071-9. https://doi.org/10.1016/j.mayocp.2012.06.014 https://pubmed.ncbi.nlm.nih.gov/22883742 
12.	Mlakar U, Andoljšek D, Fikfak N, Glaser M, Grat M, Grmek Zemljič T, et al. Smernice za odkrivanje in zdravljenje diseminiranega plazmocitoma. Zdrav Vestn. 2006;75(1):3-8. 
13.	International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121(5):749-57. https://doi.org/10.1046/j.1365-2141.2003.04355.x https://pubmed.ncbi.nlm.nih.gov/12780789 
14.	Zver S, Mlakar U. V imenu Združenja hematologov SZD. Slovenske smernice za obravnavo diseminiranega plazmocitoma 2015. Zdrav Vestn. 2015;84(5):335-51. 
15. Plazmacitne novotvorbe. Bolezni krvi in krvotvornih organov. Košnik M, Štajer D, Blinc A, Gubenšek J, Blinc A, Vilfan M, 1945. Interna medicina. 5th ed. Ljubljana: Buča; 2018. :1191-201. 
16.	Cunningham-Rundles C. How I treat common variable immune deficiency. Blood. 2010;116(1):7-15. https://doi.org/10.1182/blood-2010-01-254417 https://pubmed.ncbi.nlm.nih.gov/20332369 
17.	Hypogammaglobulinemia. 
18.	Bonilla FA. Secondary immunodeficiency due to underlying disease states, environmental exposures, and miscellaneous causes. 
19.	Ballow M, Fleischer TA. Secondary immunodeficiency induced by biologic therapies. 
20.	Vavricka SR, Burri E, Beglinger C, Degen L, Manz M. Serum protein electrophoresis: an underused but very useful test. Digestion. 2009;79(4):203-10. https://doi.org/10.1159/000212077 https://pubmed.ncbi.nlm.nih.gov/19365122 
21. Keren DF. Approach to pattern interpretation in serum. In: Keren DF, ed. Protein electrophoresis in clinical diagnosis. New York: Oxford University Press; 2003. :109-37. https://doi.org/10.1201/b13302-6 
